Assessing the Merits of a PPI Trial-Based Diagnosis for Gastroesophageal Reflux Disease: Speculations on Efficacy and Pitfalls
Foregut: The Journal of the American Foregut Society · 2021
DOI: 10.1177/26345161211024941 ↗Kurz gefasst
Fachartikel in der Zeitschrift Foregut: The Journal of the American Foregut Society, 2021. Verfasst von Afrin N. Kamal und 2 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Gastroesophageal reflux disease is a highly prevalent condition which can lead to complications in affected individuals. Given the economic implications of widespread testing, there has been interest in a symptom-based approach to diagnosis and use of short-term empiric acid suppressive therapy as a diagnostic modality. This review will highlight the background with regards to these clinical questions, the data regarding performance characteristics of establishing a symptom-based reflux diagnosis (focusing on typical, atypical, and extra-esophageal symptoms), the merits of the so-called “PPI Trial” and potential pitfalls to consider when seeing patients with suspected reflux symptoms.
Zitieren
APA
Kamal, A. N., Zikos, T. A., & Clarke, J. O. (2021). Assessing the Merits of a PPI Trial-Based Diagnosis for Gastroesophageal Reflux Disease: Speculations on Efficacy and Pitfalls. Foregut: The Journal of the American Foregut Society. https://doi.org/10.1177/26345161211024941
Vancouver
Kamal AN, Zikos TA, Clarke JO. Assessing the Merits of a PPI Trial-Based Diagnosis for Gastroesophageal Reflux Disease: Speculations on Efficacy and Pitfalls. Foregut: The Journal of the American Foregut Society. 2021. doi:10.1177/26345161211024941
BibTeX
@article{Kamal2021,
author = {Kamal, Afrin N. and Zikos, Thomas A. and Clarke, John O.},
title = {Assessing the Merits of a PPI Trial-Based Diagnosis for Gastroesophageal Reflux Disease: Speculations on Efficacy and Pitfalls},
journal = {Foregut: The Journal of the American Foregut Society},
year = {2021},
doi = {10.1177/26345161211024941}
}
EUVIMED